Literature DB >> 6615344

Hearing in congenital hypothyroidism.

F Debruyne, M Vanderschueren-Lodeweyckx, P Bastijns.   

Abstract

The hearing profile of children with congenital hypothyroidism was studied in 45 patients with thyroid gland agenesis, hypogenesis or dyshormogenesis, during adequate substitution therapy. Preliminary, secretory otitis media was found in 6 patients under the age of 6 years; in these children, hearing assessment was performed after cure of the middle ear effusion. Hearing threshold was measured either by conventional pure-tone audiometry or conditioned orientation reflex audiometry according to the patient's age (above and below 4 years). In 36 patients (80%) the auditory thresholds were normal; in the remaining 9 patients (20%) a sensorineural hearing loss of different degree was detected; in 5 cases (11%) the deafness was important and required auditory rehabilitation, with the use of a hearing aid in 4 of them. No relation could be found between hearing acuity and bone age at diagnosis of hypothyroidism or aetiology of thyroid dysfunction. It is concluded that in about one tenth of the children with congenital hypothyroidism a substantial deafness persists. The sensorineural nature of the hearing loss is in agreement with reported histological findings in congenital hypothyroid animals, where an immature development of the organ of Corti including hair cells and tectorial membrane has been observed.

Entities:  

Mesh:

Year:  1983        PMID: 6615344     DOI: 10.3109/00206098309072800

Source DB:  PubMed          Journal:  Audiology        ISSN: 0020-6091


  17 in total

1.  Evaluation of hearing loss in patients with Graves' disease.

Authors:  Dilek Berker; Hayriye Karabulut; Serhat Isik; Yasemin Tutuncu; Ufuk Ozuguz; Gonul Erden; Yusuf Aydin; Muharrem Dagli; Serdar Guler
Journal:  Endocrine       Date:  2011-08-11       Impact factor: 3.633

2.  Incidence of Hypothyroidism in Meniere's Disease.

Authors:  U P Santosh; M S Sudhakar Rao
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Mild impairment of neuro-otological function in early treated congenital hypothyroidism.

Authors:  S C Bellman; A Davies; P W Fuggle; D B Grant; I Smith
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

4.  No Dataset Left Behind: Mechanistic Insights into Thyroid Receptor Signaling Through Transcriptomic Consensome Meta-Analysis.

Authors:  Scott A Ochsner; Neil J McKenna
Journal:  Thyroid       Date:  2020-01-29       Impact factor: 6.568

Review 5.  Transcription factors in inner ear development.

Authors:  D P Corey; X O Breakefield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear.

Authors:  L A Everett; H Morsli; D K Wu; E D Green
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

7.  Pendred syndrome among patients with congenital hypothyroidism detected by neonatal screening: identification of two novel PDS/SLC26A4 mutations.

Authors:  Karolina Banghova; Eva Al Taji; Ondrej Cinek; Dana Novotna; Radka Pourova; Jirina Zapletalova; Olga Hnikova; Jan Lebl
Journal:  Eur J Pediatr       Date:  2007-09-18       Impact factor: 3.183

8.  Lipomatous myelomeningocele, athyrotic hypothyroidism, and sensorineural deafness: a new form of syndromal deafness?

Authors:  H L Peters; A Bankier
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

9.  H and B human blood-group antigen expression in cochlear hair cells is modulated by thyroxine.

Authors:  P Gil-Loyzaga; M Remezal; R Mollicone; A Ibáñez; R Oriol
Journal:  Cell Tissue Res       Date:  1994-05       Impact factor: 5.249

10.  Cochlear dysfunction in patients with acute hypothyroidism.

Authors:  Vassilis Psaltakos; Dimitrios G Balatsouras; Ioannis Sengas; Eleftherios Ferekidis; Maria Riga; Stavros G Korres
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-25       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.